Literature DB >> 14763682

Ziprasidone in Parkinson's disease psychosis.

Bernhard J Connemann, Carlos Schönfeldt-Lecuona.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14763682     DOI： 10.1177/070674370404900119

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  8 in total

1.  Ziprasidone therapy in elderly patients with psychotic mood disorders and Parkinson's disease.

Authors:  Alan L Berkowitz
Journal:  Psychiatry (Edgmont)       Date:  2006-11

2.  Drug-induced parkinsonism.

Authors:  Frandy Susatia; Hubert H Fernandez
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

3.  Parkinson's psychosis.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Curr Treat Options Neurol       Date:  2010-05       Impact factor: 3.598

Review 4.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 5.  The serotonergic system in motor and non-motor manifestations of Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox
Journal:  Exp Brain Res       Date:  2013-06-28       Impact factor: 1.972

Review 6.  Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really effective?

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  CNS Spectr       Date:  2008-03       Impact factor: 3.790

7.  Behavioral disturbances in Parkinson's disease.

Authors:  Karen E Anderson
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

8.  A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson's Disease.

Authors:  John R Younce; Albert A Davis; Kevin J Black
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.